The diagnosis was confirmed by DNA methylation profiling, which assigned the tumor to the methylation class “subependymal giant cell astrocytoma with TSC1/TSC2 alterations” with a calibrated score of 0.95. The gene discussed is TSC2; the disease is astrocytoma (excluding glioblastoma).